1. Multiple clinical features of Huntington’s disease correlate with mutant HTT gene CAG repeat lengths and neurodegeneration

   • Sonia Podvin
   • Holly T. Reardon
   • Vivian Hook

   Review 28 June 2018 Pages: 551 - 564

   

2. Kennedy’s disease (spinal and bulbar muscular atrophy): a clinically oriented review of a rare disease

   • Marianthi Breza
   • Georgios Koutsis

   Review 13 July 2018 Pages: 565 - 573

   

3. Moyamoya angiopathy: long-term follow-up study in a Finnish population

   • Marika Savolainen
   • Satu Mustanoja
   • Turgut Tatlisumak

   Original Communication Open access 17 December 2018 Pages: 574 - 581

4. Determining factors of better leptomeningeal collaterals: a study of 857 consecutive acute ischemic stroke patients

   • Stefania Nannoni
   • Gaia Sirimarco
   • Patrik Michel

   Original Communication 04 January 2019 Pages: 582 - 588

   

5. Impact of virtual reality-based rehabilitation on functional outcomes in patients with acute stroke: a retrospective case-matched study

   • Tsung-Han Ho
   • Fu-Chi Yang
   • Jiunn-Tay Lee

   Original Communication 04 January 2019 Pages: 589 - 597

   

6. Clinical effect of successful reperfusion in patients presenting with NIHSS < 8: data from the BEYOND-SWIFT registry

   • Johannes Kaesmacher
   • Panagiotis Chaloulos-Iakovidis
   • Urs Fischer

   Original Communication Open access 08 January 2019 Pages: 598 - 608

   

7. Incidence and mechanism of early neurological deterioration after endovascular thrombectomy

   • Jeong-Min Kim
   • Jae-Han Bae
   • Il-Han Yoo

   Original Communication 10 January 2019 Pages: 609 - 615

8. Adult CSF total protein upper reference limits should be age-partitioned and significantly higher than 0.45 g/L: a systematic review

   • Ari Breiner
   • David Moher
   • Pierre R. Bourque

   Original Communication 08 January 2019 Pages: 616 - 624

   

9. Cerebral small vessel disease in patients with spontaneous cerebellar hemorrhage

   • Marco Pasi
   • Andreas Charidimou
   • Anand Viswanathan

   Original Communication 08 January 2019 Pages: 625 - 630

   

10. Long-lasting diagonistic dyspraxia suppressed by rTMS applied to the right motor cortex

    • François Sellal
    • Benjamin Cretin
    • Jean-Marc Michel

    Original Communication 10 January 2019 Pages: 631 - 635

    

11. Daytime sleepiness may be an independent symptom unrelated to sleep quality in Parkinson’s disease

    • Claudio Liguori
    • Nicola Biagio Mercuri
    • Mariangela Pierantozzi

    Original Communication 03 January 2019 Pages: 636 - 641

12. Long-term tolerability, safety and efficacy of rituximab in neuromyelitis optica spectrum disorder: a prospective study

    • V. Shaygannejad
    • E. Fayyazi
    • N. Asgari

    Original Communication 11 January 2019 Pages: 642 - 650

    

13. Sensor-based algorithmic dosing suggestions for oral administration of levodopa/carbidopa microtablets for Parkinson’s disease: a first experience

    • Ilias Thomas
    • Moudud Alam
    • Jerker Westin

    Original Communication Open access 18 January 2019 Pages: 651 - 658

    

14. Continuous subcutaneous apomorphine in advanced Parkinson’s disease patients treated with deep brain stimulation

    • Ángel Sesar
    • Gustavo Fernández-Pajarín
    • Alfonso Castro

    Original Communication 07 January 2019 Pages: 659 - 666

    

15. Mills’ syndrome revisited

    • Stephan R. Jaiser
    • Dipayan Mitra
    • Mark R. Baker

    Original Communication Open access 10 January 2019 Pages: 667 - 679

    

16. Expanding the importance of HMERF titinopathy: new mutations and clinical aspects

    • Johanna Palmio
    • Sarah Leonard-Louis
    • Bjarne Udd

    Original Communication Open access 21 January 2019 Pages: 680 - 690

    

17. Patient MW: transient visual hemi-agnosia

    • Thomas Decramer
    • Elsie Premereur
    • Tom Theys

    Original Communication 07 January 2019 Pages: 691 - 698

    

18. High efficacy of rituximab for myasthenia gravis: a comprehensive nationwide study in Austria

    • Raffi Topakian
    • Fritz Zimprich
    • Wolfgang Löscher

    Original Communication 16 January 2019 Pages: 699 - 706

19. Factors interfering with parenthood decision-making in an Italian sample of people with multiple sclerosis: an exploratory online survey

    • L. Lavorgna
    • S. Esposito
    • S. Bonavita

    Original Communication 16 January 2019 Pages: 707 - 716

    

20. Painful legs and moving toes syndrome evaluated through brain single photon emission computed tomography: a case series

    • Kenya Nishioka
    • Michimasa Suzuki
    • Nobutaka Hattori

    Original Communication 14 January 2019 Pages: 717 - 725

    

21. Treatment with alemtuzumab or rituximab after fingolimod withdrawal in relapsing–remitting multiple sclerosis is effective and safe

    • Carmen Alcalá
    • F. Gascón
    • B. Casanova

    Original Communication 19 January 2019 Pages: 726 - 734

    

22. Peripheral neuropathy in hereditary spastic paraplegia caused by REEP1 variants

    • Anders Toft
    • Steffen Birk
    • Kirsten Svenstrup

    Original Communication 12 January 2019 Pages: 735 - 744

    

23. Subjective cognitive decline and progression to dementia in Parkinson’s disease: a long-term follow-up study

    • Iván Galtier
    • Antonieta Nieto
    • José Barroso

    Original Communication 11 January 2019 Pages: 745 - 754

    

24. Tollgate-based progression pathways of ALS patients

    • Özden O. Dalgıç
    • F. Safa Erenay
    • Mustafa Y. Sir

    Original Communication 25 January 2019 Pages: 755 - 765

    

25. Evolution of acute lacunar lesions in terms of size and shape: a PICASSO sub-study

    • Hyuk Sung Kwon
    • A-Hyun Cho
    • PICASSO investigators

    Original Communication 23 January 2019 Pages: 766 - 772

    

26. Differential long-term evolution after surgery or pharmacotherapy of Rasmussen encephalopathy in adult patients

    • Annalisa Parente
    • Chiara Pastori
    • Anna Rita Giovagnoli

    Letter to the Editors 04 January 2019 Pages: 773 - 774

    

27. Atypical parkinsonism with severely reduced striatal dopamine uptake associated with a 16p11.2 duplication syndrome

    • Benjamin Roeben
    • Dominik Blum
    • Matthis Synofzik

    Letter to the Editors 07 January 2019 Pages: 775 - 776

    

28. Charles Bonnet syndrome in Leber’s hereditary optic neuropathy

    • Hana Kolarova
    • Claudia B. Catarino
    • Thomas Klopstock

    Letter to the Editors 28 January 2019 Pages: 777 - 779

    

29. A case of anaphylaxis to alemtuzumab

    • Charles J. S. Nye
    • Annette Wagner
    • Alasdair J. Coles

    Letter to the Editors 04 February 2019 Pages: 780 - 781

    

30. Comparison of outcome in stroke patients admitted during working hours vs. off-hours; a single-center cohort study

    • M. P. Tuinman
    • E. G. A. van Golde
    • P. J. A. M. Brouwers

    Neurological Update 05 October 2018 Pages: 782 - 789

    

31. Population studies highlight an increased risk of dementia in both dependent and non-dependent drinkers

    • Mo Hu
    • Robin Corkill

    Journal club 12 February 2019 Pages: 790 - 792

32. George Huntington (1850–1916)

    • Michał K. Owecki
    • Anita Magowska

    Pioneers in Neurology Open access 30 April 2018 Pages: 793 - 795